| Amplification of the N-myc oncogene in an adenocarcinoma of the lung. | lung, |
| Characterization of the topoisomerase II-induced cleavage sites in the c-myc proto-oncogene. In vitro stimulation by the antitumoral intercalating drug mAMSA. | oral |
| Chromosome 8 breakpoint far 3 of the c-myc oncogene in a Burkitt s lymphoma 2;8 variant translocation is equivalent to the murine pvt-1 locus. | lymphoma, |
| Deregulation of the c-myc oncogene in virus-induced thymic lymphomas of AKR/J mice. | lymphoma, |
| Oncogenic zinc finger protein ZNF322A promotes stem cell-like properties in lung cancer through transcriptional suppression of c-Myc expression. | lung, |
| [Amplification of c-myc proto-oncogene in primary tumors, metastases and blood leukocytes of patients with ovarian cancer]. | ovarian, |
| Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. | lymphoma, |
| Site-specific hypomethylation of the c-myc oncogene in human hepatocellular carcinoma. | liver, |
| Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells. | breast, |
| Expression of c-myc oncogene product and ras family oncogene products in various human malignant lymphomas defined by immunohistochemical techniques. | lymphoma, |
| c-myc oncoprotein levels in bladder cancer. | bladder, |
| Rearrangement of the c-myc oncogene with heavy-chain immunoglobulin enhancer in tumor DNA from an acute lymphoblastic leukemia patient. | leukemia, |
| [Prognostic value of the N-myc oncogene in neuroblastoma]. | neuroblastoma, |
| HBx and c-MYC are involved in URI1 expression in HCC-B. URI1 expression may play important roles in the development and progression of HCC-B because HBx and c-MYC are well-known oncogenic factors in the virus and host | liver, |
| Amplification of the c-myc proto-oncogene in cervical carcinoma. | cervical, |
| Establishment of a peripheral T-cell lymphoma cell line showing amplification of the c-myc oncogene. | lymphoma, |
| [Immunohistochemical studies on epidermal growth factor receptor and the myc oncogene product in squamous cell carcinoma of the uterine cervix]. | uterine, |
| Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma. | lymphoma, |
| Estrogen-induced post-transcriptional modulation of c-myc proto-oncogene expression in human breast cancer cells. | breast, |
| High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix. | uterine, |